SMTL ID : 4lwv.3 (2 other biounits)

The 2.3A Crystal Structure of Humanized Xenopus MDM2 with RO5545353

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.32 Å

Oligo State

monomer

Ligands

1 x 20W: (2S,3R,4R,5R)-N-(4-carbamoyl-2-methoxyphenyl)-2'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-5'-oxo-4',5'-dihydrospiro[pyrrolidine-3,6'-thieno[3,2-b]pyrrole]-5-carboxamide(Non-covalent)

20W.1: 14 residues within 4Å: Chain A: L.30, L.33, G.34, I.37, M.38, Y.43, H.49, F.62, F.67, V.69, K.70, H.72, I.75, Y.76 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.30, A:L.30, A:L.33, A:H.49, A:V.69, A:V.69 Hydrogen bonds: A:L.30, A:G.34 pi-Stacking: A:H.72 Halogen bonds: A:H.72

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, Z. et al., Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development. ACS MED.CHEM.LETT. (2014)

Release Date

2014-07-02

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence